One of the molecules responsible for triggering the inflammation that causes allergic respiratory diseases, such as asthma and allergic rhinitis, has just been discovered by scientists from the CNRS, Inserm and the Université Toulouse III – Paul Sabatier.
Almirall to license Eloxx’s ZKN-013 for rare skin conditions
Share this article Almirall will develop and market the drug candidate for rare dermatological ailments. Credit: JPC-PROD / Shutterstock.com. Almirall has signed an exclusive licence